Search research articles
Contact Us
Filters
Showing results (131-140 of 244) with videos related to
Page
of 25
Sort By:
Scandinavian Journal of Gastroenterology
|
August 20, 2021
Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
Carl Eriksson, Isabella Visuri, Lina Vigren, et al.
Alimentary Pharmacology & Therapeutics
|
May 16, 2020
Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017
Åsa H Everhov, Rune Erichsen, Michael C Sachs, et al.
Scandinavian Journal of Gastroenterology
|
October 25, 2018
Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Sara Rundquist, Carl Eriksson, Linda Nilsson, et al.
Gut
|
June 1, 2020
Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden
Jordan E Axelrad, Ola Olén, Michael C Sachs, et al.
Gut
|
September 3, 2020
Reply: Survival in Crohn's disease-associated small bowel adenocarcinoma
Jordan E Axelrad, Ola Olén, Michael C Sachs, et al.
Gastroenterology
|
November 6, 2017
Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden
Åsa H Everhov, Jonas Halfvarson, Pär Myrelid, et al.
The Journal of Clinical Investigation
|
April 15, 2011
CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice
Hang Thi Thu Nguyen, Guillaume Dalmasso, Leif Torkvist, et al.
Clinical Epidemiology
|
March 27, 2020
Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study
Åsa H Everhov, Michael C Sachs, Jonas F Ludvigsson, et al.
BMJ Open
|
August 1, 2024
Nordic inflammatory bowel disease treatment strategy trial: protocol for the NORDTREAT randomised controlled biomarker-strategy trial
Martin Rejler, Johannes David Füchtbauer, Lóa G Davíðsdóttir, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 25, 2017
Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe
Fanni Rencz, László Gulácsi, Márta Péntek, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 244) with videos related to
Sort By:
Page
of 25
Scandinavian Journal of Gastroenterology
|
August 20, 2021
Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
Carl Eriksson, Isabella Visuri, Lina Vigren, et al.
Alimentary Pharmacology & Therapeutics
|
May 16, 2020
Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017
Åsa H Everhov, Rune Erichsen, Michael C Sachs, et al.
Scandinavian Journal of Gastroenterology
|
October 25, 2018
Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Sara Rundquist, Carl Eriksson, Linda Nilsson, et al.
Gut
|
June 1, 2020
Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden
Jordan E Axelrad, Ola Olén, Michael C Sachs, et al.
Gut
|
September 3, 2020
Reply: Survival in Crohn's disease-associated small bowel adenocarcinoma
Jordan E Axelrad, Ola Olén, Michael C Sachs, et al.
Gastroenterology
|
November 6, 2017
Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden
Åsa H Everhov, Jonas Halfvarson, Pär Myrelid, et al.
The Journal of Clinical Investigation
|
April 15, 2011
CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice
Hang Thi Thu Nguyen, Guillaume Dalmasso, Leif Torkvist, et al.
Clinical Epidemiology
|
March 27, 2020
Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study
Åsa H Everhov, Michael C Sachs, Jonas F Ludvigsson, et al.
BMJ Open
|
August 1, 2024
Nordic inflammatory bowel disease treatment strategy trial: protocol for the NORDTREAT randomised controlled biomarker-strategy trial
Martin Rejler, Johannes David Füchtbauer, Lóa G Davíðsdóttir, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 25, 2017
Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe
Fanni Rencz, László Gulácsi, Márta Péntek, et al.
Page
of 25